# Common Infectious Diseases in Africa

## Malaria

### Overview
- **Cause**: Plasmodium parasites (P. falciparum most severe)
- **Transmission**: Female Anopheles mosquito bite
- **Endemic areas**: Sub-Saharan Africa (highest burden globally)

### Clinical Presentation
- Fever (may be cyclical: every 48-72 hours)
- Chills and rigors
- Headache
- Muscle aches
- Fatigue
- Nausea and vomiting
- In children: may present with only fever

### Severe Malaria (EMERGENCY)
#### Warning Signs
- Impaired consciousness or coma
- Multiple convulsions
- Prostration (unable to sit/stand)
- Respiratory distress
- Severe anemia (Hb <5 g/dL)
- Hypoglycemia (<40 mg/dL)
- Jaundice
- Shock
- Dark/red urine (blackwater fever)

#### Risk Groups
- Children under 5
- Pregnant women
- Non-immune travelers
- HIV-positive individuals

### Diagnosis
- Rapid Diagnostic Test (RDT) - Results in 15 minutes
- Microscopy (gold standard)
- Test ALL febrile patients in endemic areas

### Treatment
#### Uncomplicated Malaria
- **First line**: Artemether-Lumefantrine (AL) or Artesunate-Amodiaquine (ASAQ)
- Duration: 3 days
- Take with fatty food (increases absorption)

#### Severe Malaria
- **First line**: IV/IM Artesunate
- Pre-referral: Rectal artesunate if injection not available
- Supportive care: fluids, glucose, transfusion if severe anemia

### Prevention
- Insecticide-treated bed nets (ITNs)
- Indoor residual spraying (IRS)
- Intermittent preventive treatment in pregnancy (IPTp)
- Seasonal malaria chemoprevention (SMC) in children
- Chemoprophylaxis for travelers

## Typhoid Fever

### Overview
- **Cause**: Salmonella typhi
- **Transmission**: Fecal-oral (contaminated water/food)
- **Incubation**: 7-14 days

### Clinical Features
- **Week 1**: Gradual onset fever (stepladder pattern), headache, malaise
- **Week 2**: High sustained fever, rose spots, splenomegaly, relative bradycardia
- **Week 3**: Complications if untreated
- Abdominal discomfort, constipation OR diarrhea
- Coated tongue

### Danger Signs
- Intestinal perforation (sudden severe abdominal pain)
- Intestinal hemorrhage (blood in stool)
- Altered consciousness (typhoid encephalopathy)
- Shock

### Diagnosis
- Blood culture (gold standard)
- Widal test (limited value - cross-reactions common)
- Typhidot IgM (rapid test)

### Treatment
- **First line**: Azithromycin or Fluoroquinolones (Ciprofloxacin)
- **Alternative**: Ceftriaxone
- Duration: 7-14 days
- Supportive care: fluids, rest, antipyretics

### Prevention
- Safe water and sanitation
- Hand hygiene
- Food safety (cook thoroughly, avoid raw foods)
- Typhoid vaccine (for travelers and endemic areas)

## Tuberculosis (TB)

### Overview
- **Cause**: Mycobacterium tuberculosis
- **Transmission**: Airborne droplets (coughing, sneezing)
- **High burden**: Africa has highest TB incidence globally

### Types
1. **Pulmonary TB** (most common, infectious)
2. **Extrapulmonary TB**: lymph nodes, spine, meninges, etc.
3. **Latent TB**: infected but not sick (not infectious)

### Symptoms - Screen All Patients
- **Cough** >2 weeks (cardinal symptom)
- **Night sweats**
- **Weight loss**
- **Fever** (especially evening)
- **Loss of appetite**
- Hemoptysis (coughing blood)
- Chest pain

### High-Risk Groups
- HIV-positive individuals
- Close contacts of TB patients
- Healthcare workers
- Prisoners
- Malnourished individuals
- Diabetics
- Children under 5

### Diagnosis
- Sputum smear microscopy (AFB)
- GeneXpert MTB/RIF (rapid, also detects rifampicin resistance)
- Chest X-ray
- Culture (gold standard but slow)

### Treatment
#### Drug-Susceptible TB (Standard Regimen)
- **Intensive phase** (2 months): RHZE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol)
- **Continuation phase** (4 months): RH
- Total: 6 months
- DOT (Directly Observed Therapy) recommended

#### Key Points
- NEVER add single drug to failing regimen
- Complete full course (even if feeling better)
- Monitor for side effects (liver, vision, neuropathy)
- Pyridoxine (vitamin B6) with isoniazid to prevent neuropathy

### TB-HIV Co-infection
- Start ART within 2 weeks for severe immunosuppression
- Start ART within 8 weeks for others
- Drug interactions: Rifampicin affects many ARVs
- Cotrimoxazole prophylaxis for all TB-HIV patients

## HIV/AIDS

### Overview
- **Cause**: Human Immunodeficiency Virus (HIV-1, HIV-2)
- **Transmission**: Sexual, blood, mother-to-child
- **Africa**: Highest global burden (68% of people living with HIV)

### Natural History
1. **Acute infection**: Flu-like illness 2-4 weeks after exposure
2. **Clinical latency**: Asymptomatic, virus replicating
3. **AIDS**: CD4 <200 or AIDS-defining illness

### Clinical Staging (WHO)
| Stage | Features |
|-------|----------|
| 1 | Asymptomatic or persistent lymphadenopathy |
| 2 | Weight loss <10%, minor skin conditions, recurrent URTIs |
| 3 | Weight loss >10%, chronic diarrhea, oral candidiasis, TB |
| 4 | HIV wasting, PCP, toxoplasmosis, cryptococcal meningitis, Kaposi's |

### Testing
- Rapid antibody tests (finger prick)
- Confirmatory testing per national algorithm
- Early infant diagnosis (PCR at 6 weeks)

### Treatment (ART)
#### When to Start
- **All HIV-positive individuals** regardless of CD4 count
- **Priority**: Pregnant women, TB co-infection, hepatitis B, severe disease

#### First-Line Regimens (Adult)
- TDF + 3TC (or FTC) + DTG (Dolutegravir-based, preferred)
- TDF + 3TC + EFV (alternative)

#### Monitoring
- Viral load at 6 months, 12 months, then annually
- Treatment success: Viral load <1000 copies/mL

### Prevention
- Consistent condom use
- PMTCT (Prevention of Mother-to-Child Transmission)
- PrEP (Pre-exposure prophylaxis) for high-risk individuals
- Post-exposure prophylaxis (PEP) within 72 hours
- Voluntary medical male circumcision

### Opportunistic Infection Prophylaxis
- **Cotrimoxazole**: All WHO stage 3/4 or CD4 <350
- **Isoniazid preventive therapy**: After ruling out active TB

## Cholera

### Overview
- **Cause**: Vibrio cholerae (O1 or O139)
- **Transmission**: Fecal-oral (contaminated water)
- **Outbreaks**: Common in areas with poor sanitation

### Clinical Features
- Sudden onset profuse watery diarrhea ("rice water" stools)
- Vomiting
- Rapid dehydration
- Leg cramps
- No fever typically

### Severity Classification
| Type | Features | Treatment |
|------|----------|-----------|
| Mild | Some dehydration | ORS at home |
| Moderate | Obvious dehydration | ORS + observation |
| Severe | Severe dehydration/shock | IV fluids + antibiotics |

### Treatment
1. **Rehydration** (most important)
   - Mild: ORS (Oral Rehydration Solution)
   - Severe: IV Ringer's Lactate rapidly, then ORS

2. **Antibiotics** (for severe cases)
   - Doxycycline (single dose)
   - Azithromycin (single dose)
   - Ciprofloxacin (alternative)

3. **Zinc** (for children)

### Prevention
- Safe water (boil or chlorinate)
- Safe food handling
- Hand washing with soap
- Proper sanitation
- Oral cholera vaccine in outbreaks

## Meningitis

### Overview
- **Causes**: Bacterial (most serious), viral, fungal
- **Meningitis belt**: Sub-Saharan Africa (seasonal epidemics)
- **Common bacteria**: N. meningitidis, S. pneumoniae, H. influenzae

### Clinical Features - Classic Triad
1. Fever
2. Headache
3. Neck stiffness (Kernig's sign, Brudzinski's sign)

### Other Features
- Photophobia
- Altered consciousness
- Vomiting
- Seizures
- Petechial rash (meningococcal - EMERGENCY)
- Bulging fontanelle in infants

### DANGER - Meningococcal Septicemia
- Non-blanching petechial/purpuric rash
- Rapidly progressive
- Shock
- **ACTION**: Immediate antibiotics (even before reaching hospital)

### Treatment
- **Empiric antibiotics**: Ceftriaxone IV immediately
- Supportive care: fluids, seizure management
- Dexamethasone (before or with first antibiotic dose)
- Lumbar puncture for diagnosis (if safe)

### Prevention
- MenACWY vaccine (routine and outbreak response)
- PCV (pneumococcal vaccine)
- Hib vaccine
- Chemoprophylaxis for close contacts (meningococcal)

## Schistosomiasis (Bilharzia)

### Overview
- **Cause**: Schistosoma parasites (S. haematobium, S. mansoni)
- **Transmission**: Fresh water contact (snail intermediate host)
- **Endemic**: Much of Africa

### Types and Features
#### S. haematobium (Urinary)
- Blood in urine (terminal hematuria)
- Painful urination
- Long-term: bladder fibrosis, cancer

#### S. mansoni (Intestinal)
- Abdominal pain
- Bloody diarrhea
- Long-term: liver fibrosis, portal hypertension

### Diagnosis
- Urine microscopy (S. haematobium - midday sample)
- Stool microscopy (S. mansoni)
- Antigen detection tests

### Treatment
- **Praziquantel** 40 mg/kg single dose
- Mass drug administration in endemic areas
- Repeat treatment annually in endemic areas

### Prevention
- Avoid contact with fresh water in endemic areas
- Safe water supply
- Sanitation
- Snail control

## Reference
Africa CDC Guidelines 2024
WHO Integrated Management Guidelines
ClinixAI Infectious Disease Module
